Overview

Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults

Status:
Completed

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and effectiveness of treatment with sublingual (s/l) Flumazenil in healthy volunteers as reversing the effect of the sleep/hypnotic drugs. This study is designed to collect short-term safety and tolerability data. In addition, the psychomotor/ cognitive and behavioral effects of Flumazenil will be assessed to monitor the degree and the duration of action in a single use of Flumazenil.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Coeruleus Ltd.

Treatments:

Brotizolam
Flumazenil
Hypnotics and Sedatives
Zolpidem